Bispecific Monoclonal Antibody

December 20, 2015

                                                                                                                

 

 

 

A bispecific monoclonal antibody is an artificial protein that is composed of fragments of two different monoclonal antibodies so it can bind to two different types of antigens. In cancer immunotherapy the bispecific monoclonal antibody is engineered to simultaneously bind to a cytotoxic cell and to a targeted tumor cell identified to be destroyed.

The antibody is showcased on the bilayer membrane of a macrophage, with its bispecific "smart bombs" ready to bind to its designated antigens.

This art received the recognition of the Member's Choice Best of Show Ralph Sweet Award and the Advertising and Marketing Award of Merit at the 2015 Salon of the Association of Medical Illustrators, 70th Annual Meeting in Cleveland, OH, and the Print Award of Excellence at the 2015 29th Annual Rx Club Show at the Metropolitan Pavilion in New York, NY.

 

 



Subscribe
RSS
Archive
January February March April May June July August September October November December (1)
January February March April May June July August September October November December